Cryoport (NASDAQ:CYRX) Announces Quarterly Earnings Results

Cryoport (NASDAQ:CYRX) released its earnings results on Tuesday. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.09), Zacks reports. Cryoport had a negative net margin of 70.08% and a negative return on equity of 13.35%. The firm had revenue of $59.53 million during the quarter, compared to the consensus estimate of $58.71 million. During the same period in the prior year, the business earned ($0.29) earnings per share. Cryoport updated its FY 2025 guidance to EPS.

Cryoport Stock Up 5.4 %

NASDAQ:CYRX opened at $5.06 on Wednesday. The firm’s 50 day simple moving average is $7.39 and its 200 day simple moving average is $7.65. The company has a debt-to-equity ratio of 0.48, a current ratio of 5.70 and a quick ratio of 5.32. Cryoport has a one year low of $4.58 and a one year high of $20.10. The company has a market cap of $250.12 million, a PE ratio of -1.50 and a beta of 1.59.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CYRX shares. Guggenheim started coverage on shares of Cryoport in a research note on Thursday, December 19th. They issued a “buy” rating and a $11.00 price target on the stock. Needham & Company LLC restated a “buy” rating and issued a $11.00 price target on shares of Cryoport in a research note on Friday, January 17th. Finally, Roth Mkm reduced their price target on shares of Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $12.29.

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.